Novel oral anticoagulants in development: Dabigatran, rivaroxaban, and apixaban

Maryam Sattari, David T. Lowenthal

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Novel oral anticoagulants in development: Dabigatran, rivaroxaban, and apixaban'. Together they form a unique fingerprint.

Medicine & Life Sciences